Optima Health plc (AIM:OPT)
247.50
-6.00 (-2.37%)
At close: Aug 14, 2026
Optima Health Ratios and Metrics
Market cap in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 269 | 160 | 152 | - | - | - | |
Market Cap Growth | 42.04% | 5.26% | - | - | - | - |
Enterprise Value | 280 | 171 | 155 | - | - | - |
Last Close Price | 2.48 | 1.79 | 1.70 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 123.75 | 113.82 | 91.89 | - | - | - |
Forward PE | 20.28 | 14.02 | 15.67 | - | - | - |
PS Ratio | 2.23 | 1.33 | 1.45 | - | - | - |
PB Ratio | 1.59 | 0.94 | 0.90 | - | - | - |
P/FCF Ratio | 19.03 | 11.29 | 170.19 | - | - | - |
P/OCF Ratio | 17.67 | 10.49 | 56.50 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.32 | 1.42 | 1.48 | - | - | - |
EV/EBITDA Ratio | 14.11 | 9.15 | 12.13 | - | - | - |
EV/EBIT Ratio | 32.33 | 19.71 | 21.86 | - | - | - |
EV/FCF Ratio | 19.81 | 12.08 | 174.23 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.74 | 0.74 | 0.13 | 0.45 | 0.45 | 0.27 |
Debt / EBITDA Ratio | 6.29 | 6.29 | 1.54 | 3.90 | 3.18 | 14.19 |
Debt / FCF Ratio | 8.83 | 8.83 | 24.31 | 4.62 | 11.17 | - |
Net Debt / Equity Ratio | 0.61 | 0.61 | 0.04 | 0.28 | 0.35 | 0.22 |
Net Debt / EBITDA Ratio | 5.53 | 5.53 | 0.54 | 2.78 | 2.72 | 12.29 |
Net Debt / FCF Ratio | 7.31 | 7.31 | 7.72 | 2.93 | 8.72 | -23.57 |
Asset Turnover | 0.42 | 0.42 | 0.48 | 0.49 | 0.55 | - |
Inventory Turnover | 343.09 | 343.09 | 883.53 | 658.52 | 746.79 | - |
Quick Ratio | 0.84 | 0.84 | 2.59 | 0.48 | 0.41 | 0.41 |
Current Ratio | 0.84 | 0.84 | 2.69 | 0.49 | 0.42 | 0.43 |
Return on Equity (ROE) | 0.83% | 0.83% | 1.12% | -0.85% | 1.25% | - |
Return on Assets (ROA) | 1.89% | 1.89% | 2.01% | 2.02% | 3.24% | - |
Return on Invested Capital (ROIC) | 1.80% | 2.20% | 2.69% | 4.30% | 6.63% | 0.48% |
Return on Capital Employed (ROCE) | 3.00% | 3.00% | 3.50% | 5.00% | 7.40% | 0.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.52% | 0.88% | 1.09% | - | - | - |
FCF Yield | 5.26% | 8.86% | 0.59% | - | - | - |
Buyback Yield / Dilution | -36.62% | -36.62% | - | - | - | - |